- Abdominal Bloating: Pathophysiology and Treatment
-
Seo AY, Kim N, Oh DH
- KMID: 2325764
- J Neurogastroenterol Motil.
- 2013 Oct;19(4):433-453.
Abdominal bloating is a very common and troublesome symptom of all ages, but it has not been fully understood to date. Bloating is usually associated with functional gastrointestinal disorders or... -
- CITED
-
- Close
- SHARE
-
- Close
- Slow Transit Constipation Associated With Excess Methane Production and Its Improvement Following Rifaximin Therapy: A Case Report
-
Ghoshal UC, Srivastava D, Verma A, Misra A
- KMID: 2326214
- J Neurogastroenterol Motil.
- 2011 Apr;17(2):185-188.
Constipation, a common problem in gastroenterology practice, may result from slow colonic transit. Therapeutic options for slow transit constipations are limited. Excessive methane production by the methanogenic gut flora, which... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic encephalopathy
-
Kim CW
- KMID: 2256159
- Korean J Med.
- 2008 Jul;75(1):27-36.
Hepatic encephalopathy, one of the major complications of cirrhosis, is a neuropsychiatric syndrome caused by accumulation of toxins in the central nervous system following dysfunction in liver detoxification. Various manifestations... -
- CITED
-
- Close
- SHARE
-
- Close
- Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori
-
Yun SP, Seon HG, Ok CS, Yoo KH, Kang MK, Kim WH, Kwon CI, Ko KH, Hwang SG, Park PW, Hong SP
- KMID: 2167415
- Gut Liver.
- 2012 Oct;6(4):452-456.
BACKGROUND/AIMS: This study assessed the efficacy of a rifaximin plus levofloxacin-based rescue regimen in patients that had failed both triple and quadruple standard regimens for the eradication of Helicobacter pylori. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of Oral Antibiotics in Elderly Gastrointestinal Patients
-
Choe SC, Lee DH
- KMID: 2339432
- J Korean Geriatr Soc.
- 2012 Sep;16(3):108-113.
Oral antibiotics are usually prescribed for geriatric patients for the treatment of infectious diarrhea and management of hepatic encephalopathy. But oral antibiotics have systemic adverse events, so many doctors face... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome
-
Chey WD, Maneerattaporn M, Saad R
- KMID: 2284205
- Gut Liver.
- 2011 Sep;5(3):253-266.
Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by episodic abdominal pain or discomfort in association with altered bowel habits (diarrhea and/or constipation). Other gastrointestinal symptoms, such... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Rifaximin Compared with Ciprofloxacin for the Treatment of Acute Infectious Diarrhea: A Randomized Controlled Multicenter Study
-
Hong KS, Kim YS, Han DS, Choi CH, Jang BI, Park YS, Lee KM, Lee ST, Kim HS, Kim JS
- KMID: 1974137
- Gut Liver.
- 2010 Sep;4(3):357-362.
BACKGROUND/AIMS: Ciprofloxacin has been widely prescribed for acute infectious diarrhea. However, the resistance to this drug is increasing. Rifaximin is a novel but poorly absorbed rifamycin derivative. This study evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- Determination of Rifaximin Treatment Period According to Lactulose Breath Test Values in Nonconstipated Irritable Bowel Syndrome Subjects
-
Bae S, Lee KJ, Kim YS, Kim KN
- KMID: 2160605
- J Korean Med Sci.
- 2015 Jun;30(6):757-762.
- doi: 10.3346/jkms.2015.30.6.757
Small intestinal bacterial overgrowth (SIBO) can partly explain irritable bowel syndrome (IBS), and rifaximin has been observed to improve abdominal symptoms in nonconstipated IBS patients. However, there are few reports... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Rifaximin and Lactulose for the Treatment of Hepatic Encephalopathy: A Prospective Randomized Study
-
Paik YH, Lee KS, Han KH, Song KH, Kim MH, Moon BS, Ahn SH, Lee SJ, Park HJ, Lee DK, Chon CY, Lee SI, Moon YM
- KMID: 1734076
- Yonsei Med J.
- 2005 Jun;46(3):399-407.
- doi: 10.3349/ymj.2005.46.3.399
Rifaximin has been reported to be effective for the treatment of hepatic encephalopathy (HE) in Europe. However, it is unknown whether Rifaximin is effective for the treatment of HE in... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Levofloxacin and Rifaximin based Quadruple Therapy in Helicobacter pylori Associated Gastroduodenal Disease: A Double-Blind, Randomized Controlled Trial
-
Choi KH, Chung WC, Lee KM, Paik CN, Kim EJ, Kang BK, Oak JH, Jung SH
- KMID: 1785965
- J Korean Med Sci.
- 2011 Jun;26(6):785-790.
- doi: 10.3346/jkms.2011.26.6.785
The aim of this study was to evaluate the efficacy of levofloxacin and rifaximin based quadruple regimen as first-line treatment for Helicobacter pylori infection. A prospectively randomized, double-blinded, parallel group,... -
- CITED
-
- Close
- SHARE
-
- Close
